Riskpilot← Back to searchSign inGet full accessRINGSAKER DYREKLINIKK AS
ASActiveOrg 989291025Storgata 114, 2390 MoelvVeterinary activities · NACE 7500Est. 20067 employees
Revenue 2025
NOK 6,4M
+14% vs 2024
EBITDA margin
11.2%
+50% vs 2024
Equity ratio
15.8%
Financial strength
Net profit 2025
NOK 498K
+68% vs 2024
| Revenue | NOK 6,4M | +14% |
| EBITDA | NOK 720K | +50% |
| Net profit | NOK 498K | +68% |
| Total assets | NOK 1,9M | +16% |
| Equity | NOK 297K | -1% |
| Employees | 7 | — |
Legal name
RINGSAKER DYREKLINIKK AS
Org number
989291025
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
20. januar 2006
Share capital
NOK 100 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Daglig leder og styrets leder i fellesskap.
Company purpose
Veterinærvirksomhet og salg av dyrefor og utstyr samt hva som herved står i forbindelse.
Address
Storgata 114, 2390 Moelv
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 5 062 | 5 096 | 5 052 | 5 621 | 6 414 |
| Staff expenses | −2 361 | −2 388 | −2 515 | −2 754 | −3 069 |
| EBITDA | 441 | 124 | 126 | 479 | 720 |
| Depreciation & amort. | −44 | −77 | −87 | −87 | −85 |
| EBIT | 397 | 47 | 39 | 391 | 635 |
| Net financials | −1 | −13 | −19 | −11 | 4 |
| Profit before tax | 396 | 33 | 21 | 380 | 639 |
| Tax | 87 | 7 | 5 | 84 | 141 |
| Net profit | 309 | 26 | 16 | 297 | 498 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 525 | 1 414 | 1 436 | 1 620 | 1 872 |
| Equity | 391 | 416 | 302 | 299 | 297 |
| Long-term debt | 8 | 287 | 239 | 181 | 115 |
| Short-term debt | 1 126 | 711 | 894 | 1 139 | 1 461 |
| Total debt | 1 134 | 998 | 1 134 | 1 321 | 1 576 |
EBITDA margin
11.2%
This company
15.8%
Market median
-29% vs market
20212025
Equity ratio
15.8%
This company
38.2%
Market median
-59% vs market
20212025
Return on equity
167.8%
This company
18.4%
Market median
+812% vs market
20212025
Net profit margin
7.8%
This company
8.1%
Market median
-4% vs market
20212025
Asset turnover
3.43×
This company
1.12×
Market median
+206% vs market
20212025
Debt / equity
5.31×
This company
0.62×
Market median
-756% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
ER Chief Executive Officer | Chief Executive Officer | 2011 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 50% | 50% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of RINGSAKER DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Rasch Arnesen | Chief Executive Officer | 0 companies |
| Monica Berg | Board of Directors | 0 companies |
| Anne Kirsti Melhus | Board of Directors | 0 companies |
| Hilde Bergaust | Board of Directors | 0 companies |
| Marlene Høyesveen | Board of Directors | 0 companies |
| Kine Elisabeth Langnes Reiersen | Chairman | 0 companies |
| Jarle Pøsche Ruud | Board of Directors | 0 companies |